Methylphenidate Hydrochloride Capsule, Extended Release
Product Images NDC 42858-077

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 42858-077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rhodes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Methylphenidate 01)

Chemical structure diagram of Methylphenidate Hydrochloride showing its molecular arrangement including a phenyl ring, ester group, and piperidine ring with associated hydrochloride.*

FDA Label Image

Figure 1 (Methylphenidate 02)

This is a pharmacokinetic line graph showing plasma concentration (ng/mL) versus time (hours) for Methylphenidate Hydrochloride 80 mg. The graph compares plasma concentrations over 24 hours between two dosage forms: Capsule and Sprinkle, with data points indicated by triangles and squares respectively.*

FDA Label Image

Figure 2 (Methylphenidate 03)

A line graph comparing SKAMP Total Scores over time (hours) between Placebo and Methylphenidate Hydrochloride ER. The x-axis represents time in hours from 0 to 14, and the y-axis shows SKAMP Total Scores ranging approximately from 0 to 2.5. Two lines are plotted: one with square markers for Placebo and one with triangular markers for Methylphenidate Hydrochloride ER, indicating lower SKAMP scores over time for the medication compared to placebo.*

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

Label for Methylphenidate Hydrochloride Extended-Release Capsules 10 mg from Rhodes Pharmaceuticals LLC. The label indicates a package of 90 capsules with a recommended dosing of once daily. It includes storage instructions and a warning to dispense the accompanying Medication Guide to each patient.*

FDA Label Image

Principal Display Panel (15 mg Capsule Bottle Label)

Label for Methylphenidate Hydrochloride Extended-Release Capsules, 15 mg strength, from Rhodes Pharmaceuticals LLC. The label indicates 90 capsules per container for oral use, prescription only. It includes storage instructions and a reminder to dispense the accompanying medication guide to each patient.*

FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Label)

Label for Methylphenidate Hydrochloride Extended-Release Capsules, 20 mg strength, in a 90-capsule bottle. The label includes the NDC number 42858-077-45 and indicates it is a Schedule II controlled substance. It is manufactured by Rhodes Pharmaceuticals LLC and requires dispensing the accompanying medication guide with each patient. The label also mentions storage instructions and a child-resistant closure.*

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

Label for Methylphenidate HCl Extended-Release Capsules 30 mg by Rhodes Pharmaceuticals LLC. The label indicates a prescription-only oral extended-release capsule, with 90 capsules per container, and instructions to dispense the accompanying medication guide. It includes storage instructions and the NDC 42858-078-45.*

FDA Label Image

Principal Display Panel (40 mg Capsule Bottle Label)

Label for Methylphenidate Hydrochloride Extended-Release Capsules 40 mg by Rhodes Pharmaceuticals LLC. The label indicates a 90-capsule bottle, with instructions to dispense the accompanying Medication Guide. It includes dosage form as extended-release capsules and states the product is Rx only.*

FDA Label Image

Principal Display Panel (50 mg Capsule Bottle Label)

Label for Methylphenidate Hydrochloride Extended-Release Capsules 50 mg by Rhodes Pharmaceuticals LLC. The label includes dosing and storage instructions, with a highlighted note to dispense the medication guide. The package contains 90 capsules and is marked for Rx only with a once daily dosage recommendation.*

FDA Label Image

Principal Display Panel (60 mg Capsule Bottle Label)

Label for Methylphenidate Hydrochloride Extended-Release Capsules 60 mg by Rhodes Pharmaceuticals LLC. The label includes the NDC number 42858-081-45 and states the dosage form as capsules, extended-release with a quantity of 90 capsules. It includes storage instructions, usage dose range, and a note to dispense the Medication Guide to patients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.